SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Hammarström L.)
 

Search: WFRF:(Hammarström L.) > (2005-2009) > Biomarker selection...

  • Ohlsson, LinaUmeå universitet,Immunologi/immunkemi (author)

Biomarker selection for detection of occult tumour cells in lymph nodes of colorectal cancer patients using real-time quantitative RT-PCR

  • Article/chapterEnglish2006

Publisher, publication year, extent ...

  • 2006-06-06
  • London :Harcourt Publishers,2006
  • printrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:umu-21205
  • https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-21205URI
  • https://doi.org/10.1038/sj.bjc.6603206DOI
  • https://lup.lub.lu.se/record/401419URI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Accurate identification of lymph node involvement is critical for successful treatment of patients with colorectal carcinoma (CRC). Real-time quantitative RT–PCR with a specific probe and RNA copy standard for biomarker mRNA has proven very powerful for detection of disseminated tumour cells. Which properties of biomarker mRNAs are important for identification of disseminated CRC cells? Seven biomarker candidates, CEA, CEACAM1-S/L, CEACAM6, CEACAM7-1/2, MUC2, MMP7 and CK20, were compared in a test-set of lymph nodes from 51 CRC patients (Dukes' A–D) and 10 controls. Normal colon epithelial cells, primary tumours, and different immune cells were also analysed. The biomarkers were ranked according to: (1) detection of haematoxylin/eosin positive nodes, (2) detection of Dukes' A and B patients, who developed metastases during a 54 months follow-up period and (3) identification of patients with Dukes' C and D tumours using the highest value of control nodes as cutoff. The following properties appear to be of importance; (a) no expression in immune cells, (b) relatively high and constant expression in tumour tissue irrespective of Dukes' stage and (c) no or weak downregulation in tumours compared to normal tissue. CEA fulfilled these criteria best, followed by CK20 and MUC2.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Hammarström, Marie-LouiseUmeå universitet,Immunologi/immunkemi(Swepub:umu)maha0008 (author)
  • Israelsson, AnneUmeå universitet,Immunologi/immunkemi(Swepub:umu)aneisn00 (author)
  • Näslund, L.Umeå universitet,Immunologi/immunkemi (author)
  • Öberg, Å.Umeå universitet,Kirurgi (author)
  • Lindmark, GudrunLund University,Lunds universitet,Kirurgi,Forskargrupper vid Lunds universitet,Surgery,Lund University Research Groups(Swepub:lu)med-gli (author)
  • Hammarström, StenUmeå universitet,Immunologi/immunkemi(Swepub:umu)stha0002 (author)
  • Umeå universitetImmunologi/immunkemi (creator_code:org_t)

Related titles

  • In:British Journal of CancerLondon : Harcourt Publishers95:2, s. 218-2250007-09201532-1827

Internet link

Find in a library

To the university's database

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view